Sarclisa

Sanofi wins appeal in spat with NICE over Sarclisa
Pharmaphorum
Wed, 11/13/24 - 10:53 am
Sanofi
NHS
NICE
relapsed or refractory multiple myeloma
Sarclisa
After Sanofi's first-line myeloma nod, J&J strikes back with new tranche of Darzalex data
Fierce Pharma
Mon, 09/30/24 - 09:30 am
Sanofi
JNJ
Sarclisa
Darzalex Faspro
Multiple Myeloma
FDA
Sanofi breaks into first-line multiple myeloma with FDA approval for Sarclisa
Fierce Pharma
Sun, 09/22/24 - 09:44 pm
Sanofi
Sarclisa
FDA
Multiple Myeloma
ASH: J&J, Sanofi square off in newly diagnosed multiple myeloma
Fierce Pharma
Wed, 12/13/23 - 09:45 am
ASH 2023
JNJ
Sanofi
Darzalex
Sarclisa
Multiple Myeloma
Sanofi’s Phase III multiple myeloma trial meets primary goal
Clinical Trials Arena
Fri, 12/8/23 - 11:02 am
Sanofi
cliincal trials
Sarclisa
Multiple Myeloma
monoclonal antibodies
ALX and Sanofi partner to start Phase l/ll trial of RRMM combo therapy
Clinical Trials Arena
Wed, 04/26/23 - 10:26 am
ALX Oncology
Sanofi
clinical trials
evorpacept
Sarclisa
relapsed or refractory multiple myeloma
Playing catch-up with J&J, Sanofi taps Blackstone for $300M to fund pivotal trial of subcutaneous Sarclisa
Fierce Pharma
Tue, 03/15/22 - 10:47 am
Sanofi
Blackstone Life Sciences
Sarclisa
Multiple Myeloma
ASH: Sanofi, Johnson & Johnson on collision course with Sarclisa, Darzalex 4-drug regimens in myeloma
Fierce Pharma
Sun, 12/12/21 - 11:33 pm
ASH2021
Sanofi
JNJ
Sarclisa
Darzalex
Multiple Myeloma
J&J and Sanofi's multiple myeloma tit-for-tat continues, as subcutaneous Darzalex wins combo approval
Endpoints
Thu, 12/2/21 - 10:57 am
JNJ
Sanofi
Multiple Myeloma
Sarclisa
Kyprolis
Darzalex
Oncology the focus for big pharma catalysts
EP Vantage
Tue, 09/28/21 - 11:19 am
Big Pharma
cancer
oncology
Merck
Keytruda
AbbVie
Vraylar
Gilead Sciences
Trodelvy
Sanofi
Sarclisa
Novartis
ligelizumab
EHA: Johnson & Johnson, nearing Sanofi showdown, bolsters Darzalex's myeloma lead with 'unprecedented' survival data
Fierce Pharma
Mon, 06/14/21 - 10:27 am
JNJ
Darzalex
Multiple Myeloma
Sanofi
Sarclisa
EHA
Sanofi keeps nipping at J&J's heels as Sarclisa notches new FDA approval in multiple myeloma
Endpoints
Thu, 04/1/21 - 10:53 am
Sanofi
JNJ
Sarclisa
Kyprolis
Multiple Myeloma
Sanofi inks $358M Kiadis takeover to acquire NK-cell platform
Fierce Biotech
Mon, 11/2/20 - 10:48 am
Sanofi
Kiadis
M&A
Sarclisa
natural killer cell therapy
Sanofi takes aim at J&J's myeloma star Darzalex with latest Sarclisa trial win
Fierce Pharma
Tue, 05/12/20 - 12:01 pm
Sanofi
Sarclisa
Multiple Myeloma
Amgen
Kyprolis
FDA Greenlights Sanofi's Sarclisa for Multiple Myeloma
BioSpace
Tue, 03/3/20 - 10:53 am
FDA
Sarclisa
Sanofi
Multiple Myeloma